Nautilus Biotechnology Statistics
Total Valuation
NAUT has a market cap or net worth of $104.72 million. The enterprise value is $6.21 million.
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025, before market open.
Earnings Date | Apr 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NAUT has 126.15 million shares outstanding. The number of shares has increased by 0.41% in one year.
Current Share Class | 126.15M |
Shares Outstanding | 126.15M |
Shares Change (YoY) | +0.41% |
Shares Change (QoQ) | +0.27% |
Owned by Insiders (%) | 32.22% |
Owned by Institutions (%) | 19.84% |
Float | 46.63M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.52 |
P/TBV Ratio | 0.51 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.40, with a Debt / Equity ratio of 0.15.
Current Ratio | 17.40 |
Quick Ratio | 17.02 |
Debt / Equity | 0.15 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.86% and return on invested capital (ROIC) is -18.89%.
Return on Equity (ROE) | -29.86% |
Return on Assets (ROA) | -18.57% |
Return on Invested Capital (ROIC) | -18.89% |
Return on Capital Employed (ROCE) | -34.65% |
Revenue Per Employee | n/a |
Profits Per Employee | -$456,645 |
Employee Count | 155 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.97% in the last 52 weeks. The beta is 1.07, so NAUT's price volatility has been similar to the market average.
Beta (5Y) | 1.07 |
52-Week Price Change | -69.97% |
50-Day Moving Average | 1.40 |
200-Day Moving Average | 2.18 |
Relative Strength Index (RSI) | 29.51 |
Average Volume (20 Days) | 142,507 |
Short Selling Information
The latest short interest is 352,327, so 0.28% of the outstanding shares have been sold short.
Short Interest | 352,327 |
Short Previous Month | 291,638 |
Short % of Shares Out | 0.28% |
Short % of Float | 0.76% |
Short Ratio (days to cover) | 2.99 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -81.48M |
Pretax Income | -69.64M |
Net Income | -70.78M |
EBITDA | -79.50M |
EBIT | -81.48M |
Earnings Per Share (EPS) | -$0.56 |
Full Income Statement Balance Sheet
The company has $129.89 million in cash and $30.48 million in debt, giving a net cash position of $99.42 million or $0.79 per share.
Cash & Cash Equivalents | 129.89M |
Total Debt | 30.48M |
Net Cash | 99.42M |
Net Cash Per Share | $0.79 |
Equity (Book Value) | 208.73M |
Book Value Per Share | 1.66 |
Working Capital | 125.19M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$59.15 million and capital expenditures -$2.88 million, giving a free cash flow of -$62.03 million.
Operating Cash Flow | -59.15M |
Capital Expenditures | -2.88M |
Free Cash Flow | -62.03M |
FCF Per Share | -$0.49 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |